Caption Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.19M Buy
+23,400
New +$2.87M 0.01% 742
2025
Q4
Sell
-50,000
Closed -$6.68M 1991
2025
Q3
$6.68M Hold
50,000
0.05% 392
2025
Q2
$6.22M Hold
50,000
0.07% 337
2025
Q1
$6.36M Hold
50,000
0.06% 317
2024
Q4
$7.2M Buy
50,000
+40,000
+400% +$5.74M 0.07% 266
2024
Q3
$1.49M Buy
+10,000
New +$1.43M 0.02% 662

Other funds holding RGEN

Caption Management's RGEN Position: Q2 2026 in Review

Caption Management sold out of Repligen (RGEN) in Q2 2026, closing a stake of 27,500 shares — an estimated $3.38M sold.

Caption Management first reported a position in RGEN in Q2 2023 and held it in 7 quarters. The position peaked at $3.86M in Q3 2025. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Caption Management reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
  • Caption Management sold 27,500 Repligen shares in Q2 2026, an estimated $3.38M.
  • Caption Management first reported a position in Repligen in Q2 2023 and held it in 7 quarters.
  • Caption Management's Repligen position peaked at $3.86M in Q3 2025.
  • 481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.